Yongye International Announces First Quarter 20... (YONGYE INTERNATIONAL INC. AND SUBSIDIARI...)

Yongye International Announces First Quarter 2010 Results

Date:5/12/2010

YONGYE INTERNATIONAL, INC. AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS For the Three Months Ended March 31, 2010 March 31, 2009 CASH FLOWS FROM OPERATING ACTIVITIES Net income $4,628,742 $3,325,306 Adjustments to reconcile net income to net cash provided by / (used in) operating activities: Depreciation and amortization 357,170 107,236 Reversal of bad debt provision -- (73,701) Decrease in fair value of derivative liabilities (12,534) (208,011) Changes in operating assets and liabilities: Accounts receivable (2,611,556) (3,302,662) Inventories (4,134,389) (1,466,830) Prepayments 132,734 (18,828) Due from a related party -- (72,763) Prepaid expenses (230,217) 97,734 Other receivables 60,371 424,992 Other assets (2,563,580) -- Accounts payable- related party -- 43,366 Accounts payable- third parties 3,688,858 -- Income tax payable 818,179 140,799 Advance from customers 2,149 (1,789,453) Accrued expenses 415,120 1,051,410 Other payables (38,885) 70,298 Net Cash Provided by / (Used in) Operating Activities 512,162 (1,671,107) CASH FLOWS FROM INVESTING

SOURCE Yongye International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/21/2013)... 2013 Custom Learning Designs, Inc.(CLD) ... solution using Tin Can API combined with its ... is a leading developer of training content and ... worldwide. , Tin Can API is a ... and trainers more accurately measure the Return on ...

(Date:5/21/2013)... May 21, 2013 The congress ... Transplant Association) is the biggest congress in ... Nearly 10,000 participants are in Istanbul ... research findings. New pioneering studies have been presented: ... PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...

(Date:5/21/2013)... York , May 21, 2013 ... Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and ... IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and ... billion in 2011 and is expected to grow at ... reach an estimated value of USD 4.7 billion in ...

(Date:5/21/2013)... May 21, 2013 MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM. The presentation will describe the ...

Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2 CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3 ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2 ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4 The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard [0] ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials [0] The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... Jan. 11 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; ... and,commercial development of technologies targeting the chronic inflammation,underlying ... at 4:10 p.m. on Wednesday, January 16, 2008. ... Time, during which management will,provide a Company update ...

... by Mark Walton, Ph.D., President, ViaGen, January 11, ... the,European Food Safety Authority,s strong endorsement of the safety ... U.S. Food and Drug,Administration to release its final risk ... voluntary moratorium. The international,scientific consensus is clear: food from ...

... Biodesign Institute have developed the worlds first gene detection ... results, appearing in the January 11 issue of the ... technology and may also revolutionize the way in which ... We are starting with the most well-known structure in ...

Cached Biology Technology:Vasogen to Conduct Year-end 2007 Conference Call 2 Vasogen to Conduct Year-end 2007 Conference Call 3 Vasogen to Conduct Year-end 2007 Conference Call 4 Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply 2 Nanotechnology innovation may revolutionize gene detection in a single cell 2 Nanotechnology innovation may revolutionize gene detection in a single cell 3

Vasogen to Conduct Year-end 2007 Conference Call Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply Nanotechnology innovation may revolutionize gene detection in a single cell

(Date:5/21/2013)... shape is an uphill battle? Try staying fit in ... withers muscle and bone. , That,s the challenge a ... a new three-year, $1.2 million grant from NASA. Their ... multiyear exploratory missions. , "You could give astronauts the ... get them to stick to it, it isn,t going ...

(Date:5/21/2013)... of insulin action in cells in precise detail like ... what goes wrong in diabetes. , The breakthrough ... from Sydney,s Garvan Institute of Medical Research, is now ... journal Cell Metabolism . , First discovered in ... in the body because it helps us lower blood ...

(Date:5/20/2013)... University of Minnesota Medical School researchers from the ... the University,s Brain Tumor Program, have developed a new ... that allow them to discover new genes and gene ... was published this week in the journal Nature ... researchers in the lab of David Largaespada, Ph.D., professor ...

Breaking Biology News(10 mins):Fueling fitness on the final frontier 2 Insight into the dazzling impact of insulin in cells 2 Insight into the dazzling impact of insulin in cells 3 U of M researchers develop model for better testing, targeting of MPNST 2

[0] Fueling fitness on the final frontier [0] Insight into the dazzling impact of insulin in cells [0] U of M researchers develop model for better testing, targeting of MPNST

... The history of evolution is periodically marked by explosions ... wide range of shapes and sizes. With a new ... record, researchers have discovered that these diversifications proceeded head-first. ... that diversified around the time of two separate extinction ...

... to help prevent or reduce severe wildfire will release more ... fire prevention, a new study concludes. There may be ... forest structure or health, wildlife enhancement or public safety ... say. In research just published in Frontiers in ...

... LIFE the Faculty of Life Sciences at the University ... growth pattern than non-breastfed children. Breastfeeding lowers the levels of ... means that growth is slightly slower. This is believed to ... The PhD project is part of SKOT, a ...

Cached Biology News:'Head-first' diversity shown to drive vertebrate evolution 2 'Head-first' diversity shown to drive vertebrate evolution 3 Forest health versus global warming: Fuel reduction likely to increase carbon emissions 2 Breastfeeding promotes healthy growth 2

'Head-first' diversity shown to drive vertebrate evolution Forest health versus global warming: Fuel reduction likely to increase carbon emissions Breastfeeding promotes healthy growth

2-min, single-step add-mix-measure assay for luciferase expression and HTS in mammalian cells. Linear detection range: 2 fg to 46 ng luciferase....

Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....

... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...

... System is used in conjunction ... PCR of problematic and/or GC-rich ... Solution with 10X PCRX Amplification ... broader magnesium concentration broader annealing ...

Biology Products:

luciferase Assay Kit, SuperLight from BioAssay Systems Anti-Endomorphin-2 Polyclonal Antibody, Unconjugated from CHEMICON CopyRight pSMART VC Blunt Cloning Kit (without cells) from Lucigen PCRX Enhancer System from Invitrogen